JOHN FREDERICK DE GROOT to Maximum Tolerated Dose
This is a "connection" page, showing publications JOHN FREDERICK DE GROOT has written about Maximum Tolerated Dose.
Connection Strength
0.050
-
Phase 1 lead-in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastoma. Cancer. 2019 02 01; 125(3):424-433.
Score: 0.030
-
Phase I trial of verubulin (MPC-6827) plus carboplatin in patients with relapsed glioblastoma multiforme. J Neurooncol. 2012 Nov; 110(2):257-64.
Score: 0.020